BIBLIOGRAPHIC RECORD

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Daniel F. Manvich; Kevin A. Webster; Stephanie L. Foster; Martilias S. Farrell; James Ritchie; Joseph H. Porter; David Weinshenker
Source of metadata
OpenAlex
Year recorded
2018

Public identifiers and source

Open the source record

Reference

Daniel F. Manvich; Kevin A. Webster; Stephanie L. Foster; Martilias S. Farrell; James Ritchie; Joseph H. Porter; David Weinshenker. (2018). The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. https://openalex.org/W2804376135

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-ecffc241f1c4ed217b1f056edfb99199/